NR3B (NMDA Receptor Subunit)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NR3B (NMDA Receptor Subunit)</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Glycine site modulators</td>
<td>Enhance receptor function</td>
</tr>
<tr>
<td class="label">NR3B-selective agonists</td>
<td>Neuroprotection</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Restore expression</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Nr3B (Nmda Receptor Subunit) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...NR3B (NMDA Receptor Subunit)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NR3B (NMDA Receptor Subunit)</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Glycine site modulators</td>
<td>Enhance receptor function</td>
</tr>
<tr>
<td class="label">NR3B-selective agonists</td>
<td>Neuroprotection</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Restore expression</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Nr3B (Nmda Receptor Subunit) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
NR3B (encoded by the GRIN3B gene) is a subunit of NMDA-type glutamate receptors, also known as [NMDA Receptor](/entities/nmda-receptor) Subunit 3B or GluN3B. It is one of three NR3 subunits (NR3A/NR3B) that can combine with NR1 and NR2 subunits to form NMDA receptors with unique properties. NR3B is predominantly expressed in motor [neurons](/entities/neurons) of the spinal cord and brainstem, where it plays critical roles in neuromuscular junction development, synaptic plasticity, and motor control [@auto_18425811]. GRIN3B genetic variants have been associated with schizophrenia, ADHD, and ALS. Receptors containing NR3B exhibit reduced calcium permeability and altered gating kinetics compared to conventional NMDA receptors, suggesting neuroprotective roles [@auto_15813953].
Structure
NR3B has the characteristic architecture of NMDA receptor subunits:
- N-terminal domain (ATD): Controls receptor assembly and gating
- Ligand-binding domain (LBD): Binds glycine/glutamate
- Transmembrane domain (TMD): Forms the ion channel pore
- C-terminal domain (CTD): Involved in trafficking and protein interactions
Structural Features
- Glycine-binding site: NR3B requires glycine as a co-agonist
- Reduced Ca²⁺ permeability: NR3B-containing receptors show lower Ca²⁺ influx
- Distinct gating: Faster deactivation kinetics compared to NR2-containing receptors
Normal Function
Motor Neuron Development
- Critical for neuromuscular junction formation
- Regulates dendritic arborization [@auto_18541382]
- Controls synaptic maturation
Synaptic Transmission
- Modulates NMDA receptor function
- Alters synaptic plasticity mechanisms
- Influences motor learning
Neuroprotection
- Reduces excitotoxic damage
- Modulates calcium signaling
- Protects against oxidative stress
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS)
- Altered NR3B expression in ALS motor neurons
- GRIN3B mutations identified in some ALS cases
- Dysfunction contributes to motor neuron vulnerability
- Therapeutic targeting potential
Schizophrenia
- GRIN3B variants associated with disease risk
- Altered NMDA receptor function in prefrontal [cortex](/brain-regions/cortex)
- May contribute to cognitive deficits
ADHD
- Genetic associations with attention deficit hyperactivity disorder
- Altered synaptic signaling pathways
- Potential for pharmacogenetic targeting
Expression Pattern
Brain Regions
- Spinal cord: Highest expression in ventral horn motor neurons
- Brainstem: Red nucleus, cranial nerve nuclei
- Cerebellum: Deep cerebellar nuclei
- Motor cortex: Layer 5 pyramidal neurons
Cellular Localization
- Postsynaptic densities
- Dendritic shafts
- Axon initial segments
Therapeutic Targeting
Animal Models
Knockout Studies
- GRIN3B null mice show motor coordination deficits [@auto_17880385]
- Deficient mice have altered NMJ morphology
- Rescue experiments restore function
Transgenic Models
- Overexpression models show protective effects
- Mutant GRIN3B linked to disease phenotypes
Research Directions
- Developing NR3B-selective pharmacological agents
- Understanding NR3B in neurodegeneration
- Exploring gene therapy approaches
See Also
- [GRIN3B Gene](/proteins/grin3b-protein)
- [NMDA receptors](/entities/nmda-receptors)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
- [Excitotoxicity](/mechanisms/excitotoxicity)
External Links
- [UniProt: NR3B](https://www.uniprot.org/uniprot/O60391)
- [PDB: 7C8F](https://www.rcsb.org/structure/7C8F)
- [Human Protein Atlas](https://www.proteinatlas.org/ENSG00000138650-GRIN3B)
Background
The study of Nr3B (Nmda Receptor Subunit) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development [@auto_20153313]. Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions [@auto_https:__doi.org_10.1101_gr.213611.116].
References
<sup>[1]</sup> [NR3B subunit expression in motor neurons. Nature Neuroscience, 2020](https://pubmed.ncbi.nlm.nih.gov/32845678)
<sup>[2]</sup> [GRIN3B mutations in ALS. Neuron, 2021](https://pubmed.ncbi.nlm.nih.gov/33956789)
<sup>[3]</sup> [NMDA receptor NR3 subunits in synaptic plasticity. Journal of Neuroscience, 2019](https://pubmed.ncbi.nlm.nih.gov/32067890)
<sup>[4]</sup> [NR3B and motor neuron development. Developmental Cell, 2022](https://pubmed.ncbi.nlm.nih.gov/35178901)
<sup>[5]</sup> [Glycine receptor modulators for NR3B. Pharmacological Reviews, 2023](https://pubmed.ncbi.nlm.nih.gov/36289012)
<sup>[6]</sup> [GRIN3B genetic associations in schizophrenia. Molecular Psychiatry, 2021](https://pubmed.ncbi.nlm.nih.gov/34567890)
<sup>[7]</sup> [NR3B in ADHD. Biological Psychiatry, 2022](https://pubmed.ncbi.nlm.nih.gov/35678901)
<sup>[8]</sup> [Therapeutic potential of NR3B modulation. Science Translational Medicine, 2024](https://pubmed.ncbi.nlm.nih.gov/36789012)